Rationale of family medicine physicians in effectively identifying patients with chronic hyperglycemia through point-of-care hemoglobin A1C screenings

被引:0
|
作者
Whitley, Heather P. [1 ,2 ]
Hanson, Courtney [3 ]
Parton, Jason M. [3 ]
Smith, Warren D. [4 ]
机构
[1] Auburn Univ, Dept Pharm Practice, Harrison Sch Pharm, Auburn, AL 36849 USA
[2] Baptist Hlth Syst, Montgomery Family Med Residency Program, 4371 Narrow Lane Rd,Suite 100, Montgomery, AL 36116 USA
[3] Univ Alabama, Inst Business Analyt, Culverhouse Coll Business, Tuscaloosa, AL USA
[4] Auburn Univ, Dept Drug Discovery & Dev, Harrison Sch Pharm, Auburn, AL 36849 USA
关键词
Diabetes; Prediabetes; Screening; A1C; Prevention; Point-of-care; IMPAIRED FASTING GLUCOSE; DIABETES-MELLITUS; BLOOD-GLUCOSE; TYPE-2; RISK; COMPLICATIONS; THERAPY;
D O I
10.1007/s40200-019-00402-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeMany patients are unknowingly living with chronic hyperglycemia, possibly due to low screening rates. We aimed to correlate detection of unidentified chronic hyperglycemia to practitioner reported rationale for conducting diabetes screening.MethodsPhysicians screened patients via a point-of-care A1C tests and recorded corresponding rationales. Elevated outcomes (A1C5.7%) were correlated to recorded rationales, frequency of repeat screenings, documented diagnoses, and therapeutic actions taken as a result of elevated A1C.ResultsNearly one-half (45%) of selected patients were unknowingly living with chronic hyperglycemia, having an average A1C of 7.92% for outcomes 6.5%. Most commonly recorded rationales were overweight status (71%), high-risk ethnicity (58%), and age>45years (48%); previously recorded A1C result of 5.7% ((2) 16.02, p<0.001) and hypertension diagnosis ((2) 10.37, p=0.0013) showed statistically significant correlation with elevated A1C outcomes. A1C results 6.5% versus 5.7-6.5% more frequently prompted repeat screenings (77% vs 20%), ICD-10 code documentation (91% vs 28%), lifestyle modification recommendations (78% vs 35%), and drug therapy initiation (78% vs 9%).ConclusionsReported rationales were largely impacted by visual inspections of age, race, and weight, and prediabetic A1C values garnered less attention compared to higher values. Utilization of POC A1C screening followed by conformational repeat testing is a practical approach to improve diagnostic rates and initiation of care for diabetes.
引用
收藏
页码:155 / 162
页数:8
相关论文
共 50 条
  • [21] Implementing point-of-care hemoglobin A1C testing in an obstetrics outpatient clinic
    Weli, Homayemem
    Farnsworth, Christopher W.
    LABORATORY MEDICINE, 2024, 55 (04) : 464 - 470
  • [22] Point-of-Care Hemoglobin A1c Testing in a Community Diabetes Prevention Program
    Mcdonnell, Marie E.
    Jahreis, Katie
    Khan, Waheed
    Bourland, Ashley C.
    Cullum-Dugan, Diana
    Hanrahan, Patricia
    Apovian, Caroline M.
    DIABETES, 2012, 61 : A308 - A309
  • [23] Retrospective Accuracy Study of Point-of-Care Hemoglobin A1c in Field Conditions
    Manthei, David M.
    Wesener, Nicholas
    Twarkowski, Denise
    Giacherio, Donald A.
    Schroeder, Lee F.
    CLINICAL CHEMISTRY, 2017, 63 (03) : 780 - 781
  • [24] Discordant Point-of-Care and Laboratory Hemoglobin A1c Concentrations in Ambulatory Settings
    Korpi-Steiner, Nichole
    Cotten, Steven W.
    Little, Randie R.
    Kirk, Deepa
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2024, 10 (02): : 519 - 522
  • [25] Hemoglobin A1c and Permissive Hyperglycemia in Patients in the Intensive Care Unit with Diabetes
    Balintescu, Anca
    Martensson, Johan
    CRITICAL CARE CLINICS, 2019, 35 (02) : 289 - +
  • [26] Accuracy of three hemoglobin A1c point-of-care systems for glucose monitoring in patients with diabetes mellitus
    Torregrosa, Maria-Eugenia
    Molina, Juan
    Argente, Carlos R.
    Ena, Javier
    ENDOCRINOLOGIA Y NUTRICION, 2015, 62 (10): : 478 - 484
  • [27] Hemoglobin A1C determination by point-of-care testing: Its correlation to standard method
    Wiwanitkit, Viroj
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2012, 6 (02) : 110 - 111
  • [28] Multicenter assessment of a hemoglobin A1c point-of-care device for diagnosis of diabetes mellitus
    Sobolesky, Philip M.
    Smith, Breland E.
    Saenger, Amy K.
    Schulz, Karen
    Apple, Fred S.
    Scott, Mitchell G.
    Wu, Alan H. B.
    Little, Randie R.
    Fitzgerald, Robert L.
    CLINICAL BIOCHEMISTRY, 2018, 61 : 18 - 22
  • [29] Evaluation of Afinion AS100 hemoglobin A1c point-of-care testing analyzer
    Hui, S. R.
    Charnot-Katsikas, A.
    Yeo, K. T.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 130 (03) : 490 - 491
  • [30] Few Point-of-Care Hemoglobin A1c Assay Methods Meet Clinical Needs
    Bruns, David E.
    Boyd, James C.
    CLINICAL CHEMISTRY, 2010, 56 (01) : 4 - 6